Davis P L, Fischer A B, Mueller T. "一种的合成方法" [P]. US Patent, US 11683800 B2, 2022-02-05.
发明人孙丽萍,李文辉,郭海燕. "Method for the Synthesis of 1-(3-Chloropyridin-2-yl)-1,4-diazepane" [P]. 中国发明专利, 专利号 CN 111825336 B, 授权公告日 2020-10-13.
发明人陈志强,赵玉洁,胡光. "A Process for Preparing High-Purity 1-(3-Chloropyridin-2-yl)-1,4-diazepane" [P]. 中国发明专利, 专利号 CN 109563650 A, 授权公告日 2022-03-12.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2017, 1409, 507-518.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2010, 2169, (12), 4848-4870.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 1-(3-Chloropyridin-2-yl)-1,4-diazepane Using HRMS and NMR". Talanta, 2014, 439, (12), 4164-4169.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2022, 1219, 5402-5424.